Ionis (IONS) Operatsion marja

Ionis Pharmaceuticals (IONS) kompaniyasining rasmiy ramzlari

Ionis Pharmaceuticals (IONS) genetik patologiyalarga qarshi dori vositalarini ishlab chiqishdan olingan royalti va litsenziyalar asosida daromad keltiradi. Operatsion foyda marjalari tashqi qiyinchiliklarga modelning reaksiyasini aks ettiradi, bunda -58.90 joriy darajani ko'rsatadi. Biznes barqarorligi tashqi hamkor zavodlariga bog'liq, RNA terapiyalarining faol R&D pipeline'i esa rekordli o'sish potentsialini taqdim etadi.

IONS - Ionis Pharmaceuticals, Inc. Operatsion marja 04.07.2022 - 19.11.2026 oraligʻida

IONS (Ionis Pharmaceuticals): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Ionis Pharmaceuticals, Inc., IONS
Isis Pharmaceuticals tayyor mahsulotlari

Operatsion marja operatsion foydaning umumiy daromadga nisbati sifatida hisoblanadi va moliyaviy hamda soliq majburiyatlarini hisobga olishdan oldingi xarajatlarni boshqarish samaradorligini o'lchaydi. Ushbu ko'rsatkich Ionis Pharmaceuticals (IONS) kompaniyasining portfelni kengaytirish bosqichida RNA terapiyasi savdolarini haqiqiy daromadga aylantirish qobiliyatini aks ettiradi va qayd etilgan operatsion marja orqali biznes modelining barqarorligini baholash imkonini beradi.

Asosiy raqobatchilar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion rentabellik Repligen Corp (RGEN)|RNA - Sotuvning operatsion rentabelligi|crisprtx.com - Sotuvning operatsion marjasi|Operatsion foyda normasi WGS|RARE - Operatsion rentabellik|Beam Tx (BEAM) - Sotuvning operatsion marjasi|SRPT (Sarepta Therapeutics Inc) - Sotuvning operatsion marjasi|TWST: Operatsion foyda koeffitsiyenti|TXG (10xgenomics.com) - Operatsion marja|NTLA (Intellia Therapeutics, Inc.) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Stoke Corp (STOK)|Operatsion faoliyat rentabelligi BioLife|Operatsion marja WVE (Wave Life Sciences Ltd)|MAZE: Operatsion foyda bo'yicha sotuv rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik